Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dexcom Inc (DXCM)

Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,353,380
  • Shares Outstanding, K 390,016
  • Annual Sales, $ 4,033 M
  • Annual Income, $ 576,200 K
  • EBIT $ 778 M
  • EBITDA $ 995 M
  • 60-Month Beta 1.51
  • Price/Sales 6.52
  • Price/Cash Flow 30.00
  • Price/Book 9.65

Options Overview Details

View History
  • Implied Volatility 45.29% (+0.58%)
  • Historical Volatility 24.63%
  • IV Percentile 55%
  • IV Rank 35.18%
  • IV High 77.57% on 10/30/25
  • IV Low 27.78% on 08/05/25
  • Expected Move (DTE 4) 1.52 (2.25%)
  • Put/Call Vol Ratio 0.71
  • Today's Volume 940
  • Volume Avg (30-Day) 4,992
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 180,376
  • Open Int (30-Day) 191,880
  • Expected Range 66.02 to 69.06

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.65
  • Number of Estimates 11
  • High Estimate 0.69
  • Low Estimate 0.59
  • Prior Year 0.45
  • Growth Rate Est. (year over year) +44.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
62.32 +8.50%
on 12/01/25
69.77 -3.08%
on 12/11/25
+4.15 (+6.54%)
since 11/28/25
3-Month
54.11 +24.97%
on 11/07/25
72.08 -6.19%
on 10/24/25
+1.16 (+1.75%)
since 09/29/25
52-Week
54.11 +24.97%
on 11/07/25
93.25 -27.49%
on 02/18/25
-12.62 (-15.73%)
since 12/27/24

Most Recent Stories

More News
DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM

NEW YORK , Dec. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit.

DXCM : 67.79 (+0.33%)
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

DXCM : 67.79 (+0.33%)
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc.(DXCM) Shareholders

NEW YORK , Dec. 23, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit.

DXCM : 67.79 (+0.33%)
1 Cash-Heavy Stock for Long-Term Investors and 2 We Avoid

1 Cash-Heavy Stock for Long-Term Investors and 2 We Avoid

TWLO : 140.28 (-0.13%)
KRT : 22.85 (+0.18%)
DXCM : 67.79 (+0.33%)
DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - DXCM

NEW YORK , Dec. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM).

DXCM : 67.79 (+0.33%)
Important December 26, 2025 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Investors of Securities Fraud Class Action Lawsuit

RADNOR, Pa. , Dec. 20, 2025 /PRNewswire/ -- The law firm of  Kessler Topaz Meltzer & Check, LLP  ( www.ktmc.com ) informs investors that securities class action lawsuits have been filed...

DXCM : 67.79 (+0.33%)
Investors who lost money on DexCom, Inc. (DXCM) should contact Levi & Korsinsky about pending Class Action - DXCM

NEW YORK , Dec. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit.

DXCM : 67.79 (+0.33%)
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Ignore

1 Cash-Producing Stock with Impressive Fundamentals and 2 We Ignore

GOLF : 82.52 (-0.61%)
DXCM : 67.79 (+0.33%)
ODFL : 158.79 (-0.44%)
DexCom, Inc. Class Action: The Gross Law Firm Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 26, 2025 - DXCM

NEW YORK , Dec. 18, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM).

DXCM : 67.79 (+0.33%)
Shareholders of DexCom, Inc. Should Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM

NEW YORK , Dec. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit.

DXCM : 67.79 (+0.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of...

See More

Key Turning Points

3rd Resistance Point 68.48
2nd Resistance Point 68.07
1st Resistance Point 67.82
Last Price 67.79
1st Support Level 67.16
2nd Support Level 66.75
3rd Support Level 66.50

See More

52-Week High 93.25
Fibonacci 61.8% 78.30
Fibonacci 50% 73.68
Fibonacci 38.2% 69.06
Last Price 67.79
52-Week Low 54.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar